On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/13/23
- Zynerba confirms does not hold cash deposits, securities at Silicon Valley Bank
- 03/13/23
- Zynerba confirms does not hold cash deposits, securities at Silicon Valley Bank
- 03/13/23
- Zynerba confirms does not hold cash deposits, securities at Silicon Valley Bank
- 01/11/23
- Zynerba publishes description of Zygel as a treatment for Fragile X syndrome
- 03/14/23
- Take-Two announces availability of WWE 2K23 icon, deluxe editions
- 02/22/23
- Snickers and WWE 2K23 to return as presenting partners at WrestleMania
- 02/21/23
- WWE announces record-setting Elimination Chamber event
- 02/17/23
- WWE up 2% after Bloomberg report on offers, McMahon asking price
WBA Walgreens Boots Alliance - 03/14/23
- Senate Democrats urge Walmart, Kroger, others to sell mifepristone
- 03/06/23
- Walgreens Boots Alliance to dispense Mifepristone where 'legally permissible'
- 03/06/23
- California 'done' with Walgreens over abortion pill stance
- 03/02/23
- Walgreens with DoorDash, Uber announce free Same Day Rx Delivery for HIV
- 03/28/23
- Viking Therapeutics initiates Phase 1 study of novel formulation of VK2735
- 03/28/23
- Viking Therapeutics jumps 32% to $12.06 after Phase 1 VK2735 trial results
- 03/28/23
- Viking Therapeutics announces results from Phase 1 trial of VK2735
- 01/09/23
- Viking Therapeutics completes enrollment in Phase 2b VOYAGE study of VK2809
- 03/28/23
- Vera Therapeutics sees balance sheet funding operations to early 2026
- 03/28/23
- Vera Therapeutics announces upcoming milestones
- 03/21/23
- Vera Therapeutics director buys $637K in common stock
- 02/09/23
- Vera Therapeutics director Seidenberg buys $2.2M in common stock
- 03/27/23
- TD Synnex names John Henry chief accounting officer
- 02/28/23
- TD Synnex announces partnership with Xcitium
- 01/10/23
- TD Synnex, Authomize partner for ITDR platform
- 01/10/23
- TD Synnex announces $1B share repurchase pact
- $88.35 /
+14.755 (+20.05%) - 03/28/23
- PVH Corp. rises 19.2%
- 03/28/23
- PVH Corp. rises 17.8%
- 03/28/23
- PVH Corp. rises 13.7%
- 03/27/23
- PVH Corp. jumps 10% to $80.80 after Q4 results, FY23 guidance beat estimates
- 10/12/22
- CJ 4DPlex says 'Top Gun: Maverick' grossed $60M in its premier formats
- 03/12/23
- Fly Intel: Top five weekend stock stories
- 03/01/23
- User reports indicate problems at Paramount+, Downdetector says
- 02/16/23
- Paramount expects to raise Paramount+ price $2.00 on premium tier
- 02/16/23
- Paramount expects slower recovery in international ad market
- 03/13/23
- PagSeguro Digital says no exposure to Silicon Valley Bank
- 01/17/23
- PagSeguro Digital falls -9.5%
- 11/23/22
- PagSeguro Digital falls -18.9%
- 11/23/22
- PagSeguro Digital falls -19.8%
- 03/27/23
- Berkshire Hathaway acquires over 4.4M Occidental shares
- 03/16/23
- Berkshire Hathaway buys 7.9M shares of Occidental Petroleum for $466.68M
- 03/07/23
- 1PointFive, Houston Astros announce direct air capture carbon removal agreement
- 03/02/23
- 1PointFive announces plan to develop a carbon capture, sequestration hub
- 03/23/23
- FiscalNote spikes 75% after announcing selected for OpenAI partnership
- 03/23/23
- FiscalNote selected as inaugural 'trusted partner' for OpenAI's ChatGPT plug-in
- 03/15/23
- FiscalNote announces Fireside State selected by Georgia Legislature
- 03/01/23
- FiscalNote sees FY22 revenue approximately $113.8M, consensus $113.56M
- 03/27/23
- Microsoft, Internews, USAID to develop Media Viability Accelerator
- 03/24/23
- CMA 'narrows scope of concerns' in Microsoft-Activision review
- 03/22/23
- Microsoft, CarbonCapture reach carbon removal credits agreement
- 03/22/23
- Syneos Health and KX team on predictive analytics, AI and ML
- 03/28/23
- McCormick rises 12.9%
- 12/05/22
- McCormick names Sarah Piper as Chief Human Relations Officer
- 11/29/22
- McCormick raises quarterly dividend to 39c from 37c per share
- 11/01/22
- McCormick Chief Human Relations Officer Lisa Manzone retiring
- 03/27/23
- Lyft announces CEO succession plan, appoints David Risher next CEO
- 03/14/23
- California court upholds treating Uber, Lyft drivers as contractors
- 02/16/23
- Lyft announces Alicia Zuiker joining as Chief People Officer
- 02/09/23
- Lyft says focus on growth will be centered around Pink
- $27.01 /
+3.055 (+12.75%) - 01/04/23
- Lovesac director buys $847K in common stock
- 12/07/22
- Lovesac reports Q3 SSS up 8.9%
- 11/03/22
- Lovesac appoints John Legg as CSCO
- 03/28/23
- Lucid Group down 6% to $7.64 following report of layoffs
- 03/27/23
- Lucid recalls 2022-2023 Lucid Air vehicles for issue with electric motors
- 02/22/23
- Lucid Group down 8% afterhours at $9.14 after Q4 results and 2023 outlook
- 02/22/23
- Lucid Group: 2023 production guidance of 10,000 -14,000 vehicles
- $30.81 /
-10.69 (-25.76%) - 03/28/23
- Harmony Biosciences 'disagrees' with Scorpion Capital's 'assertions'
- 01/09/23
- Novavax names John Jacobs as new CEO, succeeding Stanley Erck
- 01/06/23
- Harmony Biosciences CEO John Jacobs stepping down
- 11/15/22
- Harmony Biosciences director sells $9.12M in common stock
- 03/16/23
- Fox Corp. announces 'Fox Future' Studio Lot Project
- 02/14/23
- Fox Sports says Super Bowl LVII was most-streamed Super Bowl in history
- 02/08/23
- Fox Corp. announces $1B accelerated share repurchase plan
- 02/08/23
- Fox Corp. announces incremental $3B stock repurchase authorization
- 03/20/23
- Peltz says not out of Disney, but 'not in as much as we were'
- 03/13/23
- Disney CHRO Paul Richardson to depart, Sonia Coleman to succeed
- 02/26/23
- Fly Intel: Top five weekend stock stories
- 02/21/23
- Disney reports 'Ant-Man and The Wasp: Quantumania' opening totals $249.7M
- 03/16/23
- Dollar General reports total merchandise inventories, at cost, $6.8B as of Feb 3
- 03/16/23
- Dollar General raises quarterly dividend to 59c per share
- 03/07/23
- Dollar General reformulates, rebrands pet food line, Nature's Menu
- 02/23/23
- Dollar General falls 7% to $210.00 after lowering Q4, FY22 outlook
- 02/13/23
- Core & Main to acquire Landscape & Construction Supplies LLC, terms not stated
- 12/13/22
- Core & Main sees FY22 adjusted EBITDA $910M-$930M
- 11/07/22
- Core & Main to acquire Lanier Municipal Supply Co
- $30.74 /
+15.27 (+98.71%) - 03/28/23
- Biomea Fusion trading resumes
- 03/28/23
- Biomea Fusion trading halted, volatility trading pause
- 03/28/23
- Biomea Fusion announces data from ongoing Phase II study of BMF-219
- 01/17/23
- Biomea Fusion doses first patient in COVALENT-102 trial of BMF-219
- $98.41 /
+12.28 (+14.26%) - 03/28/23
- Alibaba rises 12.4%
- 03/28/23
- Alibaba to reorganize into six business groups and other investments
- 02/23/23
- Alibaba jumps 6% to $100.65 after Q3 results beat estimates
- 02/23/23
- Alibaba CEO sees 'continued recovery in consumer sentiment'
- 03/15/23
- Array Technologies reschedules earnings, needs more time to file annual report
- 03/03/23
- Avangrid announces intent to deploy more than $30M in solar trackers from Array
- 01/30/23
- Array Technologies names Manning as Chief Operations Officer
- 11/08/22
- Array Technologies appoints Jokinen to board of directors
- 03/28/23
- Semtech announces first LoRa-enabled third party products available
- 03/28/23
- Lifeist's Mikra debuts on Amazon.com
- 03/24/23
- User reports indicate problems at Amazon says Downdetector
- 03/22/23
- Amazon says Fire TV surpasses 200M devices sold globally
- 03/14/23
- CEO says AMC 'APE' conversion approved by shareholders
- 03/14/23
- AMC falls after investors approve increase in common shares
- 03/14/23
- AMC Entertainment trading resumes
- 03/14/23
- AMC shares fall 10% amid shareholder votes at special meeting
- $98.41 /
+12.28 (+14.26%) - 03/29/23 JPMorgan
- JPMorgan 'blue sky scenario' has Alibaba worth $210 per share
- 03/28/23 Truist
- Truist sees Alibaba reorganization driving accountability, shareholder value
- 03/28/23 Morgan Stanley
- Alibaba named 'Research Tactical Idea' at Morgan Stanley
- 03/28/23 Morgan Stanley
- Alibaba can unlock 'significant value' with restructuring, says Morgan Stanley
- 03/28/23 Deutsche Bank
- Lyft CEO change 'opens the door' for potential buyout, says Deutsche Bank
- 03/28/23 Wedbush
- Wedbush incrementally more positive on Lyft with 'CEO changing of guard'
- 03/15/23 Deutsche Bank
- Lyft price target raised to $12 from $11 at Deutsche Bank
- 03/14/23 Jefferies
- California ruling a 'big win' for Uber, Lyft and DoorDash, says Jefferies
WBA Walgreens Boots Alliance - 03/26/23 Barclays
- Walgreens Boots Alliance price target lowered to $43 from $45 at Barclays
- 03/22/23 Evercore ISI
- Walgreens Boots Alliance price target lowered to $35 from $36 at Evercore ISI
- 02/23/23 Loop Capital
- Loop Capital starts Walgreens Boots at Buy, sees higher growth from healthcare
- 02/22/23 Loop Capital
- Walgreens Boots Alliance initiated with a Buy at Loop Capital
- 03/29/23 BofA
- McCormick price target raised to $75 from $73 at BofA
- 03/21/23 Credit Suisse
- McCormick price target lowered to $72 from $75 at Credit Suisse
- 03/20/23 Deutsche Bank
- McCormick price target lowered to $69 from $74 at Deutsche Bank
- 03/10/23 UBS
- McCormick initiated with a Sell at UBS
- $88.35 /
+14.755 (+20.05%) - 03/29/23 Barclays
- PVH Corp. price target raised to $110 from $106 at Barclays
- 03/28/23 Credit Suisse
- PVH Corp. price target raised to $93 from $87 at Credit Suisse
- 03/21/23 UBS
- PVH Corp. price target lowered to $92 from $100 at UBS
- 03/20/23 Goldman Sachs
- PVH Corp. price target raised to $74 from $67 at Goldman Sachs
- 03/28/23 BofA
- Paramount upgraded to Buy from Neutral at BofA
- 01/31/23 Macquarie
- Paramount downgraded to Underperform at Macquarie on high ad exposure
- 01/31/23 Macquarie
- Paramount downgraded to Underperform from Neutral at Macquarie
- 01/12/23 Guggenheim
- Paramount price target raised to $22 from $20 at Guggenheim
- 02/09/23 Morgan Stanley
- Fox Corp. price target raised to $39 from $37 at Morgan Stanley
- 01/31/23 Morgan Stanley
- Fox Corp. resumed with an Equal Weight at Morgan Stanley
- 01/06/23 MKM Partners
- MKM Partners sees WWE as 'very attractive asset' if it goes for sale
- 06/02/22 Wolfe Research
- Fox Corp. assumed at Peer Perform from Outperform at Wolfe Research
- 03/28/23 BofA
- Fox downgraded to Neutral on lack of catalysts at BofA
- 03/28/23 BofA
- Fox Corp. downgraded to Neutral from Buy at BofA
- 02/09/23 Deutsche Bank
- Deutsche Bank keeps Buy on Fox Corp., raises price target to $40
- 03/28/23 TD Cowen
- Occidental Petroleum upgraded to Outperform from Market Perform at TD Cowen
- 03/27/23 Morgan Stanley
- Occidental Petroleum price target lowered to $62 from $71 at Morgan Stanley
- 03/17/23 Barclays
- Occidental Petroleum price target raised to $78 from $70 at Barclays
- 03/10/23 Mizuho
- Occidental Petroleum price target raised to $83 from $82 at Mizuho
- 03/28/23 Citi
- PagSeguro Digital upgraded to Buy from Neutral at Citi
- 03/08/23 Evercore ISI
- StoneCo added to 'Tactical Outperform' list at Evercore ISI
- 02/06/23 Citi
- PagSeguro Digital downgraded to Neutral from Buy at Citi
- 01/17/23 Credit Suisse
- PagSeguro Digital downgraded to Neutral from Outperform at Credit Suisse
- 03/28/23 Truist
- Array Technologies upgraded to Buy from Hold at Truist
- 03/22/23 Guggenheim
- Array Technologies price target lowered to $35 from $36 at Guggenheim
- 03/09/23 Citi
- Array Technologies initiated with a Neutral at Citi
- 03/07/23 Piper Sandler
- Array Technologies price target lowered to $26 from $28 at Piper Sandler
- 02/03/23 Guggenheim
- WWE price target raised to $105 from $94 at Guggenheim
- 02/03/23 Benchmark
- WWE price target raised to $95 from $86 at Benchmark
- 01/31/23 Wolfe Research
- Wolfe Research says WWE not downgraded in correction note
- 03/20/23 Citi
- Dollar General price target lowered to $230 from $240 at Citi
- 03/17/23 BMO Capital
- Dollar General price target lowered to $230 from $255 at BMO Capital
- 03/17/23 Deutsche Bank
- Dollar General price target raised to $249 from $248 at Deutsche Bank
- 03/17/23
- Gordon Haskett downgrades Dollar General with 'more questions than answers'
- 03/15/23 Wells Fargo
- Wells says Disney investors wanting Hulu sale could be disappointed
- 03/02/23 Citi
- Disney may sell its 67% stake in Hulu, says Citi
- 02/13/23 JPMorgan
- Disney reinstated with an Overweight at JPMorgan
- 02/13/23 Citi
- Disney price target lowered to $130 from $145 at Citi
- 03/28/23 BMO Capital
- Microsoft price target raised to $305 from $265 at BMO Capital
- 03/26/23 Citi
- Activision Blizzard price target raised to $91 from $88 at Citi
- 03/21/23 Morgan Stanley
- Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley
- 03/20/23 Stifel
- Alphabet resumed with a Buy at Stifel
- 03/02/23 Citi
- Lucid Group price target lowered to $11.50 from $12 at Citi
- 02/23/23 R.F. Lafferty
- Lucid Group price target lowered to $12 from $17 at R.F. Lafferty
- 02/23/23 Exane BNP Paribas
- Lucid Group downgraded to Neutral from Outperform at Exane BNP Paribas
- 02/23/23 Cantor Fitzgerald
- Lucid Group price target lowered to $13 from $18 at Cantor Fitzgerald
- $30.74 /
+15.27 (+98.71%) - 03/29/23 Citi
- Biomea Fusion price target raised to $60 from $20 at Citi
- 03/28/23 H.C. Wainwright
- Biomea Fusion price target raised to $44 from $37 at H.C. Wainwright
- 03/28/23 Piper Sandler
- Biomea Fusion price target raised to $40 from $16 at Piper Sandler
- 02/24/23 Citi
- Biomea Fusion initiated with a Buy at Citi
- 03/28/23 Raymond James
- EPR has upside if AMC were to be sold, says Raymond James
- 03/23/23 Citi
- AMC Entertainment resumed with a Sell at Citi
- 02/09/23 Macquarie
- Macquarie raises price target on top theatre pick for 2023
- 01/30/23 B. Riley
- B. Riley sees APE unit vote opening 'massive' opportunity for AMC
- 03/24/23 Barclays
- Meta Platforms price target raised to $270 from $260 at Barclays
- 03/21/23 Loop Capital
- Best Buy price gap relative to Amazon widens, says Loop Capital
- 03/21/23 JMP Securities
- JMP analysis of Amazon data shows Peloton position strengthening
- 03/29/23 Raymond James
- Viking Therapeutics price target raised to $35 from $12 at Raymond James
- 03/28/23 BTIG
- Viking Therapeutics price target raised to $31 from $20 at BTIG
- 03/28/23 Oppenheimer
- Viking Therapeutics price target raised to $30 from $20 at Oppenheimer
- 03/28/23 Stifel
- Stifel reiterates Buy on Viking Therapeutics, raises price target to $25
- $30.81 /
-10.69 (-25.76%) - 03/28/23 Mizuho
- Harmony short report 'misleading,' 'perhaps even sensational,' says Mizuho
- 03/28/23 Raymond James
- Raymond James says buy Harmony on weakness after 'low quality' short report
- 02/22/23 Mizuho
- Harmony Biosciences price target lowered to $60 from $70 at Mizuho
- 01/04/23 Piper Sandler
- Harmony Biosciences price target raised to $70 from $62 at Piper Sandler
- 12/14/22 EF Hutton
- FiscalNote assumed with a Buy at EF Hutton
- 11/15/22 Northland
- FiscalNote price target lowered to $9 from $13 at Northland
- 11/15/22 BTIG
- FiscalNote price target lowered to $11 from $14 at BTIG
- 11/14/22 DA Davidson
- FiscalNote downgraded to Neutral at DA Davidson after Q3 miss
- $27.01 /
+3.055 (+12.75%) - 12/08/22 DA Davidson
- Lovesac price target lowered to $64 from $97 at DA Davidson
- 12/08/22 Craig-Hallum
- Lovesac price target lowered to $60 from $100 at Craig-Hallum
- 12/08/22 Canaccord
- Lovesac price target lowered to $50 from $55 at Canaccord
- 09/09/22 DA Davidson
- Lovesac price target lowered to $97 from $124 at DA Davidson
- 11/09/22 Bernstein
- Two more states legalize cannabis, $3B added to TAM, says Bernstein
- 06/23/22 Canaccord
- Zynerba price target raised to $11 from $9 at Canaccord
- 04/01/22 Alliance Global Partners
- Senate remains the hurdle for MORE Act, says Alliance Global Partners
- 03/29/23 Barclays
- TD Synnex price target lowered to $103 from $109 at Barclays
- 03/28/23 Stifel
- TD Synnex price target lowered to $110 from $120 at Stifel
- 02/15/23 Barclays
- TD Synnex initiated with an Equal Weight at Barclays
- 01/11/23 Barrington
- TD Synnex price target raised to $130 from $98 at Barrington
- 01/04/23 Jefferies
- Vera Therapeutics downgraded to Hold from Buy at Jefferies
- 01/04/23 Wedbush
- Wedbush downgrades Vera Therapeutics to Neutral, lowers price target to $8
- 01/04/23 Wedbush
- Vera Therapeutics downgraded to Neutral from Outperform at Wedbush
- 01/04/23 H.C. Wainwright
- Vera Therapeutics price target lowered to $15 from $36 at H.C. Wainwright
- 02/14/23 Loop Capital
- Loop Capital starts Core & Main with Buy on balanced end market mix
- 02/13/23 Loop Capital
- Core & Main initiated with a Buy at Loop Capital
- 01/10/23 Deutsche Bank
- Core & Main price target lowered to $40 from $41 at Deutsche Bank
- 12/16/22 Citi
- Core & Main price target lowered to $22 from $26 at Citi
- 03/28/23
- Zynerba reports Q4 EPS (18c), consensus (18c)
- 11/14/22
- Zynerba reports Q3 EPS (20c), consensus (22c)
- 02/02/23
- WWE reports Q4 EPS 45c, consensus 58c
- 11/02/22
- WWE reports Q3 EPS 49c, consensus 50c
WBA Walgreens Boots Alliance - 03/28/23
- Walgreens Boots reaffirms FY23 adjusted EPS view $4.45-$4.65, consensus $4.51
- 03/28/23
- Walgreens Boots Alliance reports Q2 adjusted EPS $1.16, consensus $1.10
- 03/27/23
- Notable companies reporting before tomorrow's open
- 02/08/23
- Viking Therapeutics reports Q4 EPS (26c), consensus (23c)
- 10/26/22
- Viking Therapeutics reports Q3 EPS (21c), consensus (23c)
- 03/28/23
- Vera Therapeutics reports 2022 EPS ($3.35), consensus ($3.12)
- 11/09/22
- Vera Therapeutics reports Q3 EPS (91c), consensus (72c)
- 03/28/23
- TD Synnex sees Q2 adjusted EPS $2.25-$2.75, consensus $2.82
- 03/28/23
- TD Synnex reports Q1 adjusted EPS $2.93, consensus $2.85
- 01/10/23
- TD Synnex sees Q1 EPS $2.60-$3.00, consensus $3.05
- 01/10/23
- TD Synnex reports Q4 EPS $3.44, consensus $2.91
- $88.35 /
+14.755 (+20.05%) - 03/27/23
- PVH Corp. sees FY23 EPS roughly $8.97, consensus $8.92
- 03/27/23
- PVH Corp. sees Q1 EPS roughly $1.90, consensus $1.88
- 03/27/23
- PVH Corp. reports Q4 adjusted EPS $2.38, consensus $1.67
- 11/30/22
- PVH Corp. raises FY22 EPS view to $8.25 from $8, consensus $7.89
- 02/16/23
- Paramount sees Q1 OIBDA similar to Q4; expects a Q1 EPS loss
- 02/16/23
- Paramount reports Q4 adjusted EPS 8c, consensus 24c
- 02/15/23
- Notable companies reporting before tomorrow's open
- 11/23/22
- PagSeguro Digital reports Q3 net income R$380.3M vs. R$321.5M last year
- 02/27/23
- Occidental Petroleum reports Q4 adjusted EPS $1.61, consensus $1.81
- 11/08/22
- Occidental Petroleum reports Q3 adjusted EPS $2.44, consensus $2.46
- 03/28/23
- FiscalNote sees FY23 revenue $136M-$141M, consensus $138.39M
- 03/28/23
- FiscalNote sees Q1 revenue $31M-$32M, consensus $32.47M
- 03/28/23
- FiscalNote reports Q4 EPS (32c) vs (1c) last year
- 03/01/23
- FiscalNote sees FY23 revenue $136M - $141M, consensus $135.78M
- 01/24/23
- Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29
- 01/24/23
- Notable companies reporting after market close
- 10/25/22
- Microsoft sees FX decreasing total revenue growth by 5% in FY23
- 10/25/22
- Microsoft reports Q1 EPS $2.35, consensus $2.30
- 03/28/23
- McCormick sees 2023 adjusted EPS $2.56-$2.61, consensus $2.57
- 03/28/23
- McCormick reports Q1 adjusted EPS 59c, consensus 51c
- 01/26/23
- McCormick sees FY23 EPS $2.56-$2.61, consensus $2.90
- 01/26/23
- McCormick reports Q4 adjusted EPS 73c, consensus 86c
- 02/09/23
- Lyft reports Q4 active riders up 8.7% y/y
- 02/09/23
- Lyft sees Q1 revenue roughly $975M, consensus $1.09B
- 02/09/23
- Lyft reports Q4 adjusted EBITDA ($248.3M) vs ($47.6M) last year
- 02/09/23
- Notable companies reporting after market close
- $27.01 /
+3.055 (+12.75%) - 03/28/23
- Lovesac sees 2024 EPS $1.83-$2.24, consensus $2.10
- 03/28/23
- Lovesac sees Q1 EPS (36c)-(37c), consensus (6c)
- 03/28/23
- Lovesac reports Q4 EPS $1.74, consensus $1.72
- 12/07/22
- Lovesac reports Q3 EPS (55c), consensus (76c)
- 02/22/23
- Lucid Group reports Q4 EPS (28c), consensus (40c)
- 02/22/23
- Notable companies reporting after market close
- 11/08/22
- Lucid Group reports Q3 EPS (40c), consensus (31c)
- 11/08/22
- Notable companies reporting after market close
- $30.81 /
-10.69 (-25.76%) - 02/21/23
- Harmony Biosciences reports Q4 non-GAAP EPS $1.01, consensus 58c
- 11/01/22
- Harmony Biosciences reports Q3 non-GAAP EPS 95c vs 41c last year
- 02/08/23
- Fox Corp. reports Q2 adjusted EPS 48c, consensus 48c
- 02/07/23
- Notable companies reporting before tomorrow's open
- 11/01/22
- Fox Corp. reports Q1 adjusted EPS $1.21, consensus $1.14
- 02/08/23
- Disney reports Q1 EPS ex-items 99c, consensus 78c
- 02/08/23
- Notable companies reporting after market close
- 11/08/22
- Disney CFO sees FY23 cash content spend in low-$30B range
- 11/08/22
- Disney reports Q4 EPS ex-items 30c, consensus 57c
- 03/16/23
- Dollar General sees FY23 EPS growth 4%-6%, consensus $11.43
- 03/16/23
- Dollar General reports Q4 EPS $2.96, consensus $2.96
- 02/23/23
- Dollar General cuts FY22 EPS growth view to 4.5%-5% from 7%-8%
- 02/23/23
- Dollar General cuts Q4 EPS view to $2.91-$2.96 from $3.15-$3.30, consensus $3.24
- 03/28/23
- Core & Main sees FY23 revenue $6.455B-$6.875B, consensus $6.34B
- 03/28/23
- Core & Main reports Q4 EPS 31c, consensus 32c
- 12/13/22
- Core & Main reports Q3 EPS 65c, consensus 57c
- $30.74 /
+15.27 (+98.71%) - 03/28/23
- Biomea Fusion reports Q4 EPS (21c), consensus (81c)
- 11/07/22
- Biomea Fusion reports Q3 EPS (78c), consensus (65c)
- $98.41 /
+12.28 (+14.26%) - 02/23/23
- Alibaba reports Q3 adjusted EPS $2.79, consensus $2.37
- 02/22/23
- Notable companies reporting before tomorrow's open
- 11/17/22
- Alibaba reports Q2 adjusted EPS $1.82, consensus $1.64
- 03/21/23
- Array Technologies sees FY23 adjusted EPS 75c-85c, consensus 78c
- 03/21/23
- Array Technologies reports Q4 adjusted EPS 10c, consensus 8c
- 03/21/23
- Notable companies reporting after market close
- 03/02/23
- Array Technologies sees 2023 adjusted EPS 75c-85c, consensus 95c
- 02/02/23
- Amazon sees Q1 revenue $121B-$126B, consensus $125.11B
- 02/02/23
- Amazon reports Q4 EPS 3c with Rivian loss, consensus 17c
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Amazon sees Q4 revenue $140B-$148B, consensus $155.15B
- 02/28/23
- AMC Entertainment reports Q4 adjusted EPS (14c), consensus (21c)
- 02/28/23
- Notable companies reporting after market close
- 11/08/22
- AMC Entertainment reports Q3 adjusted EPS (20c), consensus (25c)
|